Advertisement
Research ArticleMetabolism, Transport, and Pharmacogenomics
Open Access

Pharmacological Evaluation of Dotinurad, a Selective Urate Reabsorption Inhibitor

Tetsuya Taniguchi, Naoki Ashizawa, Koji Matsumoto, Ryo Saito, Keisuke Motoki, Miku Sakai, Noriko Chikamatsu, Chiharu Hagihara, Masamichi Hashiba and Takashi Iwanaga
Journal of Pharmacology and Experimental Therapeutics October 2019, 371 (1) 162-170; DOI: https://doi.org/10.1124/jpet.119.259341

Article Information

vol. 371 no. 1 162-170
DOI 
https://doi.org/10.1124/jpet.119.259341
PubMed 
31371478
Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0022-3565
Online ISSN 
1521-0103
History 
  • Received April 24, 2019
  • Accepted July 16, 2019
  • Published online September 17, 2019.

Article Versions

Copyright & Usage 
Copyright © 2019 The Author(s). This is an open access article distributed under the CC BY Attribution 4.0 International license.

Author Information

  1. Tetsuya Taniguchi,
  2. Naoki Ashizawa,
  3. Koji Matsumoto,
  4. Ryo Saito,
  5. Keisuke Motoki,
  6. Miku Sakai,
  7. Noriko Chikamatsu,
  8. Chiharu Hagihara,
  9. Masamichi Hashiba, and
  10. Takashi Iwanaga
  1. Research Laboratories 2, Fuji Yakuhin Co., Ltd., Nishi Ward, Saitama City, Saitama, Japan (T.T., N.A., K.Ma., K.Mo., M.S., N.C., C.H., T.I.) and Research Center, Mochida Pharmaceutical Co., Ltd., Jimba, Gotemba City, Shizuoka, Japan (R.S., M.H.)
  1. Address correspondence to:
    Tetsuya Taniguchi, Research Laboratories 2, Fuji Yakuhin Co., Ltd., 636-1 Iida-Shinden, Nishi Ward, Saitama City, Saitama, 331-0068, Japan. E-mail: t-taniguchi{at}fujiyakuhin.co.jp
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: August 2019 to December 2024

AbstractFullPdf
Aug 20192280148
Sep 201994221119
Oct 201924195127
Nov 201927225113
Dec 20193621098
Jan 202025242129
Feb 202049237177
Mar 20208228156
Apr 2020420882
May 20208173123
Jun 20207159105
Jul 2020813266
Aug 2020712786
Sep 20201115696
Oct 20208176112
Nov 2020511266
Dec 202022114113
Jan 2021810083
Feb 20211010099
Mar 202112143114
Apr 202149141117
May 202152103100
Jun 2021911776
Jul 202118122108
Aug 2021117970
Sep 202167977
Oct 20218107108
Nov 202158384
Dec 202139968
Jan 202277666
Feb 2022108667
Mar 2022810571
Apr 202258063
May 20221610375
Jun 202299578
Jul 202276644
Aug 202266941
Sep 202266664
Oct 202275645
Nov 2022159660
Dec 202256446
Jan 202356243
Feb 2023196362
Mar 202366857
Apr 2023105274
May 202326757
Jun 2023136153
Jul 202367963
Aug 202398879
Sep 202388765
Oct 2023166049
Nov 202365655
Dec 2023614157
Jan 20245011756
Feb 20241918240
Mar 2024109148
Apr 20241123184
May 20242024538
Jun 2024148249
Jul 20242611287
Aug 2024227161
Sep 2024148166
Oct 202489960
Nov 202439792
Dec 2024109168

Back to top

In this issue

Download PDF
Article Alerts
Email Article
Citation Tools

Research ArticleMetabolism, Transport, and Pharmacogenomics

Dotinurad Selectively Inhibits Urate Reabsorption Transporter

Tetsuya Taniguchi, Naoki Ashizawa, Koji Matsumoto, Ryo Saito, Keisuke Motoki, Miku Sakai, Noriko Chikamatsu, Chiharu Hagihara, Masamichi Hashiba and Takashi Iwanaga
Journal of Pharmacology and Experimental Therapeutics October 1, 2019, 371 (1) 162-170; DOI: https://doi.org/10.1124/jpet.119.259341
Twitter logo Facebook logo Mendeley logo

Jump to section

Advertisement